Stran (SWAG) Q2 2026 Earnings Call Transcript

Stran (SWAG) reported Q2 2026 revenue of $33.4M, up 2.4% YoY. Stran segment revenue grew 6.9% YoY, while SLS segment revenue declined 6.5%. Gross profit increased 1.6% to $10.0M, with gross margin at 30.0%. Net income was $309K, down from $643K YoY. The company secured new contracts and improved SLS gross margin to 24.3%. Management expects public warrant expiration in Q4 2026.

Original reporting
Published Aug 18, 2026, 11:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 18, 2026, 11:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Stran (SWAG) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$SWAGNeutralMed
01

Why it matters

Key trading takeaways are the mix shift driving gross margin changes, consolidated profitability deterioration (operating income, EBITDA, net income vs prior year), and new contract wins framed as early revenue contributors.

02

Market read

Traders get a fresh snapshot of revenue growth with weaker consolidated profitability, plus capital-structure simplification expectations and contract announcements that could influence forward revenue quality.

03

What to watch

SLS revenue decline is attributed to timing and program size variability, so quarter-to-quarter comparisons may overstate weakness; traders may need to focus on contract conversion and digital platform monetization over multiple quarters.

Relevance 7/10Novelty 6/10Timing: after-hours earnings call transcript dated Aug. 12, 2026

Background

The transcript covers Stran & Company’s Q2 2026 results, segment performance (Stran core vs SLS), technology investment, and expected public warrant expiration in 4Q26.

Company-level read

Ticker impact

$SWAGNeutralMedium confidence
Context

Stran reported Q2 2026 revenue of $33.4M (+2.4% YoY) and detailed segment margin changes plus warrant-expiration timing in 4Q26.

Expected impact

Near-term volatility likely around margin and operating income deterioration versus SLS gross margin improvement and new contract commentary.

Evidence & confidence

The article includes multiple new datapoints (quarterly financials, segment margins, operating income/net income declines, and 4Q26 warrant expiration expectation) that can shift trader expectations, but it lacks explicit guidance or consensus-beating context.

Market effects

Promotional products and loyalty/distribution peers may watch for evidence that digital platform investment is translating into segment-level margin gains.

No clear regional read-through beyond U.S. customer verticals (grocery and casino/gaming).

Limited, as the disclosed contracts and segment commentary appear U.S.-centric.

Counterpoint

Operating income and EBITDA declined year over year, so margin improvement in SLS may not be durable if Stran Digital Solutions spending continues to pressure consolidated profitability.

Key entities

  • Stran & Company

    Subject of the earnings call transcript, reporting Q2 2026 financials, segment margin changes, new contracts, and expected 4Q26 warrant expiration.

  • Andrew Shape

    CEO who discussed land-and-expand strategy, SLS margin drivers, and technology investment posture.

  • David Browner

    CFO who discussed operating expense changes and segment performance drivers.

Related articles

$SWAGMed

Stran & Company Reports 32% Increase in Third Quarter 2026 Gross Profit as Gross Margin Expands to 33.3%

Stran & Company, Inc. (SWAG) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Stran & Company Reports 32% Increase in Third Quarter 2026 Gross Profit as Gross Margin Expands to 33.3% Nine-Month Net Income of $1.1 Million, an Improvement of $2.1 Million Over the Prior-Year Period Conference Call to be Held Wednesday, November 11, 2026 at 10:00

$SWAGMed

Stran & Company Reports $33.4 Million in Revenue and $0.6 Million in EBITDA for the Second Quarter of 2026

Stran & Company, Inc. (SWAG) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Stran & Company Reports $33.4 Million in Revenue and $0.6 Million in EBITDA for the Second Quarter of 2026 Conference Call to be Held Wednesday, August 12, 2026 at 10:00 a.m. Eastern Time Quincy, MA / August 11, 2026 / Stran & Company, Inc. (“Stran” or the “Company”)

$GOSSMed

Gossamer Bio Announces Third Quarter 2026 Financial Results and Provides Business Update

Gossamer Bio, Inc. (GOSS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Gossamer Bio Announces Third Quarter 2026 Financial Results and Provides Business Update – New Drug Application for Seralutinib in PAH Submitted to the U.S. FDA in September 2026 – – Structured Private Placement Provides $25 Million Upfront and Up to $125 Million of

$GSLHighAI 8/10

Global Ship Lease, Inc. (GSL): Financial results for Q3 2026

Global Ship Lease, Inc. (GSL) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Investor and Media Contacts: IGB Group Bryan Degnan 646-673-9701 or Leon Berman 212-477-8438 Global Ship Lease Reports Results for the Third Quarter of 2026 Annualized dividend to increase to $2.75 per Class A Common Share Further de-risked our newbuilding program wi

$AZTAMedAI 8/10

Azenta Reports Fourth Quarter and Full Year Results for Fiscal 2026, Ended September 30, 2026

Azenta, Inc. (AZTA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Azenta Reports Fourth Quarter and Full Year Results for Fiscal 2026, Ended September 30, 2026. • Q4'26 reported revenue growth of 5% year over year and 2% on an organic basis • FY'26 reported revenue growth of 5% year over year and 2% on an organic basis • FY'27 repo